256376-65-5Relevant academic research and scientific papers
PROCESS FOR THE PREPARATION OF METHYL 4,6-DIAMINO-2-[L-(2-FHIOROBENZVR)-LH-PYRAZOLO I3,4-BLPVRIDIN-3-VN-5-PYRIMIDINYL(METHVL)CARBAMATE AND ITS POLYMORPHS THEREOF
-
Page/Page column 33, (2017/03/08)
The present invention relates to process for the preparation of methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-lH-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl(methyl)carbamate and its polymorphs thereof compound of formula-1, represented by the following structur
Preparation method and application of pyrazolo[3, 4-b]pyridine compound intermediate
-
, (2016/10/17)
The invention provides a preparation method and application of a pyrazolo[3, 4-b]pyridine compound intermediate. Specifically, the intermediate structure is shown as formula IV, wherein the groups are defined as the specification and claims. The intermedi
METHOD FOR SYNTHESIZING 1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDINE-3-FORMAMIDINE HYDROCHLORIDE
-
Paragraph 0026; 0027; 0028, (2014/10/29)
The present invention relates to the field of chemical synthesis, and in particular to a method for synthesizing 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-formamidine hydrochloride, which is an important intermediate of Riociguat that is an anti-thro
Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b] pyridines as soluble guanylate cyclase stimulators
Griebenow, Nils,Schirok, Hartmut,Mittendorf, Joachim,Straub, Alexander,Follmann, Markus,Stasch, Johannes-Peter,Knorr, Andreas,Schlemmer, Karl-Heinz,Redlich, Gorden
, p. 1197 - 1200 (2013/03/28)
Novel guanylate cyclase stimulators are disclosed. Design, synthesis, SAR, and pharmacological profile of the compounds are discussed.
Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses
-
Page/Page column 15, (2010/02/16)
The present application relates to novel heterocyclyl-substituted fused pyrazole derivatives, to processes for their preparation, to their use, alone or in combination, for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders.
Novel Combination Containing a Stimulator of Soluble Guanylate Cyclase and a Lipid-Lowering Substance
-
Page/Page column 9, (2010/11/28)
A combination product which comprises as pharmaceutically active ingredients at least one active ingredient component A and at least one active ingredient component B, where active ingredient component A is a direct soluble guanylate cyclase stimulator of
NOVEL 2,5-DISUBSTITUTED PYRIMIDINE DERIVATIVES
-
Page/Page column 30, (2010/02/06)
The invention relates to novel 2,5-disubstituted pyrimidine derivatives, which stimulate the soluble guanylate cyclase, method for production and use thereof for the production of medicaments, in particular medicaments for the treatment of central nervous system diseases.
4-AMINO-SUBSTITUTED PYRIMIDINE DERIVATIVES
-
Page/Page column 22, (2010/02/06)
The invention relates to novel 4-amino-substituted pyrimidine derivatives, which stimulate soluble guanylate cyclase, method for production and use thereof for the production of medicaments, in particular medicaments for the treatment of diseases of the c
PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVE
-
Page/Page column 12, (2010/02/06)
The invention relates to a substituted pyrazole derivative and the use thereof as a medicament, particularly as a medicament for treating cardiovascular diseases.
Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
-
Page column 43, (2010/02/07)
The present invention relates to novel substituted pyrazole derivatives of the general formula (I) in which R1, R2, R3and A are each as defined, and to processes for their preparation and to their use as medicaments, in pa
